INDUSTRY SYMPOSIUM 3

 

13:15 - 15:15    Elicium 1

 

Individualization of HD therapy - the way to address clinical challenges
 
Chair: Claudio Ronco, Vicenza, Italy
 
Who benefits from HDF and why, based on recent clinical trials?
Paul Cockwell, Birmingham, UK
 
How to prevent intradialytic hypotension while reducing volume overload?
Rajiv Agarwal, Indianapolis, USA
  
Dialysis standard of care for high-bleeding-risk HD patients - what the HepZero study tells us
Maurice Laville, Lyon, France
 
Organised by GAMBRO

 

back to the timetable